Aclaris Therapeutics, Inc.
ACRS
$1.15
$0.076.48%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -132.07M | -37.00M | -58.68M | -77.26M | -88.48M |
| Total Depreciation and Amortization | 807.00K | 892.00K | 932.00K | 908.00K | 863.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 100.26M | -6.98M | -3.13M | -1.21M | -96.00K |
| Change in Net Operating Assets | 10.92M | 25.19M | -3.58M | 4.78M | 9.39M |
| Cash from Operations | -20.08M | -17.90M | -64.46M | -72.79M | -78.33M |
| Capital Expenditure | -121.00K | -562.00K | -646.00K | -891.00K | -1.31M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -69.65M | 27.07M | 56.89M | 38.15M | 47.53M |
| Cash from Investing | -69.77M | 26.50M | 56.24M | 37.26M | 46.22M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 80.03M | 907.00K | 890.00K | 27.63M | 27.63M |
| Repurchase of Common Stock | -409.00K | -76.00K | -168.00K | -157.00K | -102.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.09M | -826.00K | -826.00K | -826.00K | -826.00K |
| Cash from Financing | 74.54M | 5.00K | -104.00K | 26.65M | 26.71M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.31M | 8.61M | -8.32M | -8.88M | -5.40M |
